Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Enadenotucirev |
Trade Name | |
Synonyms | EnAd|ColoAd1|ColoAd-1 |
Drug Descriptions |
Enadenotucirev is a conditionally-replicating group B adenovirus that has antitumor and immunomodulating activity (PMID: 26708004, PMID: 32532291). |
DrugClasses | |
CAS Registry Number | 1402042-02-7 |
NCIT ID | C113786 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Capecitabine + Enadenotucirev | Capecitabine Enadenotucirev | 0 | 1 |
Enadenotucirev | Enadenotucirev | 0 | 0 |
Enadenotucirev + Pembrolizumab | Enadenotucirev Pembrolizumab | 0 | 1 |